Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

One Dipping Stock Hedge Funds Like and a Healthcare Company Smart Money is Not Bullish On

Page 1 of 2

As the markets started the end of the week on a negative note, amid almost unchanged wholesale prices and in the anticipation of the next week’s Fed meeting. Several stocks stood out above the crowd as they displayed significant moves in pre-market and extended them into the first hours of trading. In this article we will take a closer look at three of those stocks and the respective hedge fund sentiment that surrounds each one of them. This will provide a better insight regarding each movement and will suggest whether these stocks have long-term potential to gain more ground.

motherboard, circuit, chip, Intel, Micron, Qualcomm, AMD

Generally, investors don’t pay as much attention to how hedge funds are trading a stock, mainly because these figures are obtained from 13F filings, which are filed with a significant delay compared to the actual time of the transaction. However, most investors forget the fact that hedge funds invest for the long-term and assessing their 13F filings can provide many opportunities for piggybackers. We conducted backtests that involved imitating hedge funds’ picks between 1999 and 2012 and used a 60-day delay to be on the safe side and still obtained some interesting results. The main focus of our tests were hedge funds’ small-cap ideas and 15 most popular of them managed to outperform the market by some 95 basis points per month on average. Based on these results, we launched our small-cap strategy in August 2012, and it has returned over 118% since then, beating the market by some 60 percentage points (read more details here).

With this in mind, let’s start to analyze the stocks that caught our attention right after the bell. One of them is Marvell Technology Group Ltd. (NASDAQ:MRVL), which lost over 20% in pre-market on the back of preliminary financial results, but started to regain some of the ground and currently trades down by 16%. The company posted its preliminary results for the second quarter of fiscal 2016 ended August 1, which included revenue of $711 million and GAAP Net Loss of $0.74 per share. The semiconductor company reported $962 million in revenue and EPS of $0.27 posted a year earlier.

The hedge funds from our database are bullish on Marvell Technology, as at the end of June 36 investors held $694.90 million worth of stock, compared to 33 funds holding positions valued at $1.03 billion in aggregate. Still, as the stock lost 10% during the second quarter, the investors overall increased their holdings, which amassed over 10% of the company at the end of June. Among these investors, the two largest stakes are held by Cliff Asness’ AQR Capital Management and David Shaw’s D.E. Shaw, which own 12.27 million shares and 9.50 million shares as of the end of June, respectively. It’s also worth mentioning that AQR boosted its position by 43% on the quarter, while Shaw cut its stake by 20%.

On the other hand, David Einhorn’s Greenlight Capital unloaded its entire position in Marvell Technology Group Ltd. (NASDAQ:MRVL) that previously contained 9.05 million shares. In his letter to investors, Einhorn said that the position was closed because of declining PC market. “…we didn’t see as much earnings power in the core storage and networking business and decided to sell,” Einhorn said (see more details here).

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!